Ishita Drugs & Industries Ltd.
| BSE: 524400 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE806D01016 |
| BSE 00:00 | 16 Sep | 38.20 |
0.50 (1.33%) |
OPEN
38.00 |
HIGH
39.50 |
LOW
38.00 |
| NSE 05:30 | 01 Jan | Ishita Drugs & Industries Ltd |
| OPEN | 38.00 |
| PREVIOUS CLOSE | 37.70 |
| VOLUME | 794 |
| 52-Week high | 54.00 |
| 52-Week low | 19.00 |
| P/E | 13.04 |
| Mkt Cap.(Rs cr) | 11 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Ishita Drugs & Industries Ltd. (ISHITADRUGS) - Announcements
-
Ishita Drugs & Industries Ltd INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION 2015
31/08/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd INTIMATION OF E-VOTING PEROID ALONG WITH THE NOTICE OF 28TH ANNUAL GENERAL MEETING (AGM)
31/08/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd INTIMATION ABOUT 28TH ANNUAL GENERAL MEETING (AGM) & BOOK CLOSURE
31/08/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Reg. 34 (1) Annual Report
31/08/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2021 Pursuant To Regulation 3
13/08/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Consider Approve And Take On Re
07/08/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Shareholding for the Period Ended June 30 2021
16/07/2021 | bse
-
Ishita Drugs & Industries Ltd Statement Of Investor Complaints For The Quarter Ended June 2021
13/07/2021 | bse
-
Ishita Drugs & Industries Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13/07/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regu
12/07/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Closure of Trading Window
01/07/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Outcome Of Board Meeting
30/06/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Board Meeting Intimation for Consider Approve And Take On Records The Audited Financial Statement O
23/06/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
09/06/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
21/04/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requiremen
16/04/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosu
15/04/2021 | bse |
Downlaod PDF -
Ishita Drugs & Industries Ltd Shareholding for the Period Ended March 31 2021
14/04/2021 | bse
-
Ishita Drugs & Industries Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
14/04/2021 | bse
-
Ishita Drugs & Industries Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09/04/2021 | bse |
Downlaod PDF
Quick Links for Ishita Drugs & Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
